Table 2 Factors related to provision of IPTp in health facilities
Variable | Urban | Rural | Total (%) | ||
|---|---|---|---|---|---|
| Â | Public | Private | Public | Private | Â |
| Â | 11 | 3 | 17 | 3 | 34 |
How IPTp is delivered | |||||
 IPTp is offered in the facility | 10 | 2 | 15 | 2 | 29 (85.3) |
 DOT is practiced in the facility | 3 | 1 | 3 | 0 | 7 (20.6) |
 Woman is given drug to take home | 7 | 1 | 12 | 2 | 22 (64.7) |
Where drug used for IPTp is sourced | |||||
 Free from Ministry of Health | 10 | 0 | 15 | 0 | 25 (73.5) |
 Purchased | 0 | 2 | 0 | 2 | 4 (11.7) |
Facility occasionally has periods of drug stock-out | 6 | 1 | 4 | 1 | 12 (35.3) |
Source of drugs during stock-out | |||||
 Direct acquisition from market for sale | 1 | 1 | 1 | 1 | 4 (11.8) |
 Woman is given prescription to purchase on her own | 5 | 0 | 3 | 0 | 8 (23.5) |
Facilities with drugs on day of interview | |||||
 SP | 11 | 3 | 15 | 3 | 32 (94.1) |
 ACT | 8 | 3 | 16 | 3 | 30 (88.2) |
 Quinine | 7 | 1 | 5 | 3 | 16 (47.1) |
Complaints about the drug | |||||
 Side effect | 1 | 2 | 2 | 1 | 6 (17.6) |
 Irregularity of drug availability | 0 | 0 | 2 | 0 | 2 (5.9) |